drugset / Trial / NCT03916198

Polydeoxyribonucleotide (PDRN) for Cuff Regeneration

NCT03916198

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is to evaluate the effect of polydeoxyribonucleotide (PDRN) for healing and fatty degeneration of rotator cuff. The investigators will enroll 130 patients with rotator cuff tear who will undergo arthroscopic rotator cuff repair. 130 patients will be classified into two group. One group (PDRN) will be injected at the repaired cuff with 3cc polydeoxyribonucleotide just after surgery and be injected with another 3ml polydeoxyribonucleotide under ultrasound guidance 2 weeks after the surgery. The other group (CONTROL) will be injected with 3ml normal saline in the same manner.

Timeline

Start
2019-05-09
Primary completion
2021-08-09
Completion
2022-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Polydeoxyribonucleotide Unknown 3 ml Other

Indications